Financials: Bill.com Earnings, Lemonade&#39;s New Product, and the Latest Fintech SPAC IPO

Reach us by Email @ IndustryFocus@fool.com

Feb 08,2021 • 39:06

Listen to Financials: Bill.com Earnings, Lemonade's New Product, and the Latest Fintech SPAC IPO

Recent Episodes

CG: FarFetch and the Business of Luxury E-tailing

Motley Fool analyst Yasser El-Shimy makes his Industry Focus debut as he joins host Emily Flippen to talk about one of the largest and most successful e-retailer of luxury goods: Farfetch (FTCH).

Check out more of our content here:

Reach us by Email @ IndustryFocus@fool.com

Mar 02, 2021 • 44:21 • Industry Focus

Listen

Financials: An Interview With Payoneer's CEO and 2 SPACs We're Watching

In this week's installment of Industry Focus: Financials, Fool.com contributor and SPAC investor Matt Frankel interviews Scott Galit, CEO of Payoneer, a fintech disruptor that recently agreed to go public via merger with FTAC Acquisition(NYSE: FTOC). Then, Frankel and host Jason Moser discuss two other SPACs investors might want to put on their radar -- one value-seeking SPAC that just agreed to take a data center operator public, and one SPAC sponsored by a retail heavyweight that just launched.

Check out more of our content here:

Reach us by Email @ IndustryFocus@fool.com

Mar 01, 2021 • 44:01 • Industry Focus

Listen

Tech: Whoa Olo!

We're back on the S-1 hunt, this time looking at the books for Olo, a SaaS provider that helps big brand restaurants stand up their digital storefronts and make delivery happen.

It's a high growth business in a booming market and it's surprisingly profitable. We explain why it'll be near the top of our watch lists once it is public.

Stocks: OLO

Check out more of our content here:

Reach us by Email @ IndustryFocus@fool.com

Feb 26, 2021 • 35:53 • Industry Focus

Listen

Energy: Gold, Bitcoin, and You

This week, Jason Hall and Anand Chokkavelu join the podcast to discuss the role gold, bitcoin, and other so-called “alternative” assets can play in an individual investor’s portfolio.

Stocks/Cryptocurrencies Mentioned: Bitcoin

Check out more of our content here:

Reach us by Email @ IndustryFocus@fool.com

Feb 25, 2021 • 35:54 • Industry Focus

Listen

Wildcard: Is Clover Health a Disruptor or Distractor?

Clover Health (NASDAQ: CLOV) has been one of the most controversial Medicare insurance providers since being brought public by Social Capital and Hedosophia. In this Wildcard episode, Motley Fool contributor Jason Hall and analyst Emily Flippen discuss Clover’s business, its unique value proposition, and then debate if the controversial short-seller report should have investors running for the door.

Check out more of our content here: